Do the CRP rs1205 and TNF rs1800629 variants affect inflammatory tone?

C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) are critical mediators of the human inflammatory response. Genetic variations in their respective genes, CRP and TNF, play a significant role in determining an individual's baseline inflammatory tone and their magnitude of response to physiological stress.

Clinical and effectiveness evidence

Research into these two specific variants confirms they are potent modulators of inflammatory signaling, though their effects are highly dependent on the genetic and clinical context.

• TNF rs1800629 (-308G>A): This variant is a well-established driver of increased inflammatory signaling. A large volume of evidence, including functional studies in healthy individuals and meta-analyses in disease cohorts, shows that the A allele (TNF2) is associated with higher production of TNF-alpha. In studies of stimulated peripheral blood mononuclear cells, carriers of the A allele consistently demonstrate higher cytokine release compared to G allele homozygotes.
• CRP rs1205: The relationship between this variant and CRP levels is more complex and population-dependent. In the general healthy population, the T allele is actually associated with 15–30% lower high-sensitivity CRP (hs-CRP) levels. However, in specific populations—such as patients with aortic stenosis—the relationship flips, with T allele carriers showing significantly higher hs-CRP (e.g., 2.53 mg/L vs. 1.68 mg/L).

Mechanistic explanations

The biological impact of these variants stems from how they alter gene expression at the molecular level.

• TNF-alpha Transcriptional Activation: The rs1800629 variant is located in the promoter region of the TNF gene. The G to A substitution creates a more potent transcriptional activator site, which increases the rate of TNF-alpha mRNA synthesis. This elevated TNF-alpha then acts as a primary ligand for TNF receptors, triggering the NF-κB pathway—a master regulator of the systemic inflammatory response.
• CRP mRNA Stability: The rs1205 variant is located in the 3' untranslated region (UTR) of the CRP gene. Mechanistically, it influences inflammatory marker levels by modulating the stability of CRP mRNA. While the T allele typically destabilizes the mRNA (leading to lower protein production), this post-transcriptional control can be modified by intense systemic inflammatory signaling, such as high IL-6 or interferon signatures, which explains why its effect can vary across different disease states and populations.

Bottom line

Both genetic variants are significant modulators of inflammation: the TNF rs1800629 A allele consistently increases TNF-alpha production and NF-κB signaling, while the CRP rs1205 variant acts as a context-dependent regulator that can lead to higher CRP levels in specific clinical populations despite lowering them in healthy individuals.